These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Familial pheochromocytomas and paragangliomas: stories from the sign-out room. Perren A; Komminoth P Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482 [TBL] [Abstract][Full Text] [Related]
4. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588 [TBL] [Abstract][Full Text] [Related]
5. Update on Paragangliomas and Pheochromocytomas. Lam AK Turk Patoloji Derg; 2015; 31 Suppl 1():105-12. PubMed ID: 26177321 [TBL] [Abstract][Full Text] [Related]
13. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas. Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741 [TBL] [Abstract][Full Text] [Related]
15. An update on the genetics of pheochromocytoma. Karasek D; Shah U; Frysak Z; Stratakis C; Pacak K J Hum Hypertens; 2013 Mar; 27(3):141-7. PubMed ID: 22648268 [TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. Elder EE; Elder G; Larsson C J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371 [TBL] [Abstract][Full Text] [Related]
17. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma. Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839 [TBL] [Abstract][Full Text] [Related]
18. The genetic basis of pheochromocytoma. Gimm O; Koch CA; Januszewicz A; Opocher G; Neumann HP Front Horm Res; 2004; 31():45-60. PubMed ID: 14674304 [TBL] [Abstract][Full Text] [Related]
19. A Guide to Pheochromocytomas and Paragangliomas. Guilmette J; Sadow PM Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301 [TBL] [Abstract][Full Text] [Related]
20. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Favier J; Igaz P; Burnichon N; Amar L; Libé R; Badoual C; Tissier F; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP Endocr Pathol; 2012 Mar; 23(1):34-42. PubMed ID: 22183643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]